{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:22Z","timestamp":1791593842294,"version":"4.3.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2021,4,13]]},"abstract":"<jats:p>Background: Parkinson\u2019s disease (PD) is a neurodegenerative condition with a diverse and complex pattern of motor and non-motor symptoms which change over time with disease duration. Objective: The aims of the present study were to discover what symptoms matter most to people with the condition and to examine how these priorities change with disease duration. Methods: A simple free-text online survey (using SmartSurvey) was developed by Parkinson\u2019s UK, which asked participants to identify up to three aspects of the condition they would most like to see improvement in. Results: 790 people participated reporting 2,295 issues related to PD which were grouped into 24 broad symptom domains. Of these, 1,358 (59.1%) were categorised as motor symptoms, 859 (37.4%) as non-motor issues and 78 (3.4%) as medication problems. This study reveals how certain features of PD become more or less important to patients as the condition progresses. Non-motor symptoms were highly cited from the very earliest stages of PD. Problems with walking, balance and falls, speech problems, freezing and dyskinesia become increasingly important as the condition progresses whereas tremor, stiffness and psychological health become decreasingly important as the condition progresses. Conclusions: The data suggest that the priorities of people affected by PD for improving life are personal and change with duration of the condition. These findings have implications for developing person-centred management and care, as well as for directing future research to improve quality of life.<\/jats:p>","DOI":"10.3233\/jpd-202346","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:50:06Z","timestamp":1610481006000},"page":"715-724","source":"Crossref","is-referenced-by-count":90,"title":["People with Parkinson\u2019s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?"],"prefix":"10.1177","volume":"11","author":[{"given":"Rebecca J.","family":"Port","sequence":"first","affiliation":[{"name":"Parkinson\u2019s UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rumsby","sequence":"additional","affiliation":[{"name":"Research Support Network, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Brown","sequence":"additional","affiliation":[{"name":"Research Support Network, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneesa","family":"Amjad","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.","family":"Bale","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-202346_ref2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: A unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JPD-202346_ref3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-202346_ref4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JPD-202346_ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.3233\/JPD-202346_ref6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.2012.04192.x","article-title":"Progression of motor and nonmotor features of Parkinson\u2019s disease and their response to treatment","volume":"74","author":"Vu","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JPD-202346_ref7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/01.wnl.0000183359.50822.f2","article-title":"Progression of motor impairment and disability in Parkinson disease: A population-based study","volume":"65","author":"Alves","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JPD-202346_ref8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ejn.14094","article-title":"The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications","volume":"49","author":"Greenland","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-202346_ref9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression","volume":"89","author":"Lawton","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-202346_ref10","doi-asserted-by":"crossref","first-page":"e006434","DOI":"10.1136\/bmjopen-2014-006434","article-title":"Priority setting partnership to identify the top 10 research priorities for the management of Parkinson\u2019s disease","volume":"4","author":"Deane","year":"2014","journal-title":"BMJ Open"},{"key":"10.3233\/JPD-202346_ref11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/JPRLS.S140697","article-title":"Descriptive symptom terminology used by Parkinson\u2019s patients and caregivers","volume":"7","author":"Mursaleen","year":"2017","journal-title":"J Parkinsonism Restless Legs Syndr"},{"key":"10.3233\/JPD-202346_ref12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2011.05.006","article-title":"The importance of non-motor disturbances to quality of life in Parkinson\u2019s disease","volume":"310","author":"Martinez-Martin","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.3233\/JPD-202346_ref13","first-page":"236","article-title":"Non motor versus motor symptoms: How much do they matter to health status in Parkinson\u2019s disease?","volume":"2","author":"Hinnell","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JPD-140446","article-title":"A survey of Parkinson\u2019s disease patients: Most bothersome symptoms and coping preferences","volume":"4","author":"Uebelacker","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-202346_ref15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson\u2019s disease symptoms: The patient\u2019s perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2147\/NDT.S196930","article-title":"Patient and physician perceptions of disease management in Parkinson\u2019s disease: Results from a US-based multicenter survey","volume":"15","author":"Hermanowicz","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JPD-202346_ref17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fneur.2018.00628","article-title":"Impact of tremor on patients with early stage Parkinson\u2019s disease","volume":"9","author":"Heusinkveld","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-202346_ref18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"Amulticenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important non-motor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of Parkinson\u2019s disease: Non-motor symptoms of Parkinson\u2019s disease","volume":"8","author":"Lee","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.26170","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson\u2019s disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref22","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mds.27461","article-title":"Fatigue in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"33","author":"Siciliano","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202346_ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.smrv.2016.08.001","article-title":"A systematic review of the literature on disorders of sleep and wakefulness in Parkinson\u2019s disease from 2005 to 2015","volume":"35","author":"Chahine","year":"2017","journal-title":"Sleep Med Rev"},{"key":"10.3233\/JPD-202346_ref24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","article-title":"Co-morbidity and polypharmacy in Parkinson\u2019s disease: Insights from a large Scottish primary care database","volume":"17","author":"McLean","year":"2017","journal-title":"BMC Neurol"},{"key":"10.3233\/JPD-202346_ref25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0193945916670904","article-title":"Self-reported symptoms of Parkinson\u2019s disease by sex and disease duration","volume":"39","author":"Shin","year":"2017","journal-title":"West J Nurs Res"},{"key":"10.3233\/JPD-202346_ref26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3233\/JPD-160922","article-title":"Challenges of improving patient-centred care in Parkinson\u2019s disease","volume":"7","author":"Mathur","year":"2017","journal-title":"J Parkinsons Dis"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-202346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:49:10Z","timestamp":1777610950000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-202346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":25,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jpd-202346","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]}}}